stars 1 stars 2 stars 3

Vesselon Inc. develops patentable drugs using an FDA-approved, biophysically activatable lipid microsphere and self-assembling liposome platform. It produces unprecedented levels of efficacy by transforming how drugs are received and acted upon by tissues and cells. The platform can extend patents and create an endless stream of proprietary drugs. View Vesselon's digital Town Hall event at https://vesselon.com/townhall/.

Vesselon Questions

The Vesselon annual revenue was $4 million in 2026.

Clay Larsen is the President and CEO, Co-Founder of Vesselon.

2 people are employed at Vesselon.

Vesselon is based in Norwalk, Connecticut.

The NAICS codes for Vesselon are [54171, 541714, 541, 54, 5417].

The SIC codes for Vesselon are [87, 873].

Top Vesselon Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users